Open AccessA Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer
Author(s) -
A.J. McRee,
P.K. Marcom,
D.T. Moore,
W.C. Zamboni,
Z.A. Kornblum,
Z. Hu,
R. Phipps,
C.K. Anders,
K. Reeder-Hayes,
L.A. Carey,
K.E. Weck,
C.M. Perou,
E.C. Dees
Publication year - 2018
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/v7dw-k684
Subject(s) - capecitabine , metastatic breast cancer , oncology , medicine , breast cancer , cancer , colorectal cancer